| Guideline | Drug Name |
|---|---|
| Nilotinib Products- PA, NF | Danziten (nilotinib tartrate), Nilotinib (nilotinib D-tartrate), Tasigna (nilotinib hydrochloride) |
| Ninlaro (ixazomib citrate) | Ninlaro (ixazomib citrate) |
| Nitisinone Products - PA, NF | Brand Orfadin capsules, Brand Orfadin oral suspension, Generic nitisinone capsules, Harliku (nitisinone), Nityr (nitisinone) tablets |
| Non-Formulary & Excluded Drug Exceptions Process for Drugs of Clinical Concern | |
| Non-GLP-1 Agonist Anorexiants – PA, NF | Contrave (naltrexone/bupropion), Generic phentermine, Adipex-P (phentermine), Lomaira (phentermine), generic phentermine-topiramate, Qsymia (phentermine and topiramate), Xenical (orlistat) |
| Non-steroidal Anti-Inflammatory Agents - PA, ST | Cambia (diclofenac) powder, Celebrex (celecoxib), Fenopron, Indocin, Indomethacin Suspension 25mg/5ml, Lofena, Meloxicam oral suspension 7.5mg/5mL, Pennsaid (diclofenac sodium) topical solution, Sprix (ketorolac tromethamine) nasal spray, Tolectin (tolmetin), Vivlodex, Zipsor (diclofenac potassium), Zorvolex (diclofenac) |
| Nonpreferred Adalimumab - PA, NF - Standard Default | Drug Name: Abrilada (adalimumab-afzb), Cyltezo (adalimumab-adbm), Hadlima (adalimumab-bwwd), Hulio (adalimumab-fkjp), Hyrimoz (adalimumab-adaz), Idacio (adalimumab-aacf), Simlandi (adalimumab-ryvk), Yuflyma (adalimumab-aaty), Yusimry (adalimumab-aqvh), Amjevita (adalimumab-atto), Humira (adalimumab) |
| Nplate (romiplostim) | Nplate (romiplostim) |
| Nucala (mepolizumab) | Nucala (mepolizumab) |
| Nuplazid (pimavanserin) | Nuplazid (pimavanserin) |
| Obesity GLP-1 Agonists – PA, NF | Saxenda (liraglutide), Wegovy Injection (semaglutide), Wegovy Tablet (semaglutide), Zepbound (tirzepatide) Injection |
| Octreotide Products - PA, NF | Mycapssa (octreotide capsule, delayed release), Sandostatin (octreotide acetate), Bynfezia Pen (octreotide acetate), Sandostatin LAR Depot (octreotide acetate) |
| Odomzo (sonidegib) | Odomzo (sonidegib) |
| Ogsiveo (nirogacestat) | Ogsiveo (nirogacestat) |
| Olumiant (baricitinib) | Olumiant (baricitinib) |
| Omega-3-Acid Derivatives | Generic icosapent ethyl, Lovaza (omega-3-acid ethyl esters), Vascepa (icosapent ethyl) |
| Oncology Injectable | ABECMA, ADCETRIS, ADSTILADRIN, ALIQOPA, ANKTIVA, ARZERRA, AUCATZYL, BAVENCIO, BELEODAQ, BESPONSA, BIZENGRI, BLENREP, BLINCYTO, BREYANZI, CARVYKTI, COLUMVI, CYRAMZA, DANYELZA, DATROWAY, ELAHERE, ELREXFIO, ELZONRIS, EMPLICITI, EMRELIS, ENHERTU, EPKINLY, ERBITUX, ERIBULIN MESYLATE, FIRMAGON, FOLOTYN, FYARRO, HALAVEN, IMFINZI, IMJUDO, INLEXZO, ISTODAX, JEMPERLI, KADCYLA, KEYTRUDA, KEYTRUDA QLEX, KIMMTRAK, KYMRIAH, KYPROLIS, LIBTAYO, LUNSUMIO, LYMPHIR, LYNOZYFIC, MARGENZA, MONJUVI, MYLOTARG, OPDIVO, OPDIVO QVANTIG, OPDUALAG, PADCEV, PERJETA, PHESGO, POLIVY, PORTRAZZA, POTELIGEO, PRALATREXATE, PROVENGE, ROMIDEPSIN, RYBREVANT, RYLAZE, SARCLISA, TALVEY, TECARTUS, TECENTRIQ, TECENTRIQ HYBREZA, TECVAYLI, TIVDAK, TRODELVY, UNLOXCYT, VYLOY, YERVOY, YESCARTA, ZALTRAP, ZEPZELCA, ZIIHERA, ZUSDURI, ZYNLONTA, ZYNYZ |
| Onpattro (patisiran) & Tegsedi (inotersen) | Onpattro (patisiran), Tegsedi (inotersen) |
| Onureg (azacitidine) | Onureg (azacitidine) |
| Ophthalmic Antihistamines | ZERVIATE (cetirizine) |
HEALTHY LIVING